First case in Italy of acquired resistance to oseltamivir in an immunocompromised patient with influenza A/H1N1v infection

J Clin Virol. 2010 Jul;48(3):220-2. doi: 10.1016/j.jcv.2010.03.027. Epub 2010 May 5.

Abstract

A pandemic influenza A/H1N1v strain with the neuraminidase H274Y mutation was detected in nasal secretions of a 2-year-old leukemic patient with influenza-like illness after 18 days of treatment with oseltamivir. At baseline, no drug-resistant virus was found, while 4 days after treatment initiation a mixture of wild-type and mutated virus was detected. After treatment interruption, the wild type influenza virus re-emerged and became prevalent in nasal secretions after a few days, suggesting the lower fitness of the mutated virus strain. The patient slowly improved concurrently with a decrease in virus load, which resulted negative 42 days after diagnosis. No other drug-resistant influenza A/H1N1v virus strains have been detected in Italy (up to the end of November 2009) since the first case of the novel A/H1N1v virus was identified in the country (May 2009).

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Substitution / genetics
  • Antiviral Agents / pharmacology*
  • Bodily Secretions / virology
  • Child, Preschool
  • Drug Resistance, Viral*
  • Female
  • Humans
  • Immunocompromised Host
  • Influenza A Virus, H1N1 Subtype / drug effects*
  • Influenza A Virus, H1N1 Subtype / isolation & purification
  • Influenza, Human / drug therapy
  • Influenza, Human / virology*
  • Italy
  • Molecular Sequence Data
  • Mutation, Missense
  • Neuraminidase
  • Nose / virology
  • Oseltamivir / pharmacology*
  • Oseltamivir / therapeutic use
  • RNA, Viral / genetics
  • Sequence Analysis, DNA
  • Treatment Outcome
  • Viral Load
  • Viral Proteins
  • Withholding Treatment

Substances

  • Antiviral Agents
  • RNA, Viral
  • Viral Proteins
  • Oseltamivir
  • NA protein, influenza A virus
  • Neuraminidase

Associated data

  • GENBANK/GU216651